## Consolidated Statement of Equity

**Year Ended**

|  | Jun 30, 2023 | Jun 30, 2022 |
| --- | --- | --- |
|       Total Stockholders' Equity - Beginning balance | 166,542 | 141,988 |
| *        Derivatives* | (27) | (13) |
| *        Accumulated other comprehensive income (loss)* | (6,343) | (4,678) |
| *        Cumulative effect of accounting changes - Accumulated other comprehensive income (loss)* |  |  |
| *        Cumulative effect of accounting changes - Retained earnings* |  |  |
| *        Cumulative effect of accounting changes - Investments* |  |  |
| *        Translation adjustments and other* | (2,734) | (2,527) |
| *        Common stock and paid-in capital* | 93,718 | 86,939 |
| *        Retained earnings* | 118,848 | 84,281 |
| *        Investments* | (3,582) | (2,138) |
|       Common stock issued - Beginning balance |  |  |
| *        Common stock and paid-in capital - Ending balance* | 1,866 | 1,841 |
|       Net Income - Beginning balance | 72,361 | 72,738 |
| *        Service Life* | 3,000 |  |
| *        Retained earnings - Ending balance* | 72,361 | 72,738 |
|       Other comprehensive loss - Beginning balance | (1,665) | (6,500) |
| *        Accumulated other comprehensive income (loss)* | (1,665) | (6,500) |
| *        Translation adjustments and other* | (207) | (1,146) |
| *        Investments* | (1,444) | (5,360) |
| *        Derivatives - Ending balance* | (14) | 6 |
|       Common stock cash dividends - Beginning balance | 20,233 | 18,550 |
| *        Retained earnings - Ending balance* | 20,226 | 18,552 |
|       Common stock repurchased - Beginning balance |  |  |
| *        Share Repurchase Program 2021* | 18,400 |  |
| *        Share Repurchase Program 2019* |  |  |
| *        Retained earnings* | 17,568 | 26,960 |
| *        Common stock and paid-in capital* | 4,696 | 5,688 |
| *        Share Repurchase Program 2019 and 2021 - Ending balance* |  | 28,033 |
|       Stock-based compensation expense - Beginning balance |  |  |
| *        Common stock and paid-in capital - Ending balance* | 9,611 | 7,502 |
|       Other, net - Beginning balance |  |  |
| *        Common stock and paid-in capital - Ending balance* | 2 | (173) |
|       Total Stockholders' Equity | 206,223 | 166,542 |
| *        Derivatives* | (27) | (13) |
| *        Accumulated other comprehensive income (loss)* | (6,343) | (4,678) |
| *        Cumulative effect of accounting changes - Accumulated other comprehensive income (loss)* |  |  |
| *        Cumulative effect of accounting changes - Retained earnings* |  |  |
| *        Cumulative effect of accounting changes - Investments* |  |  |
| *        Translation adjustments and other* | (2,734) | (2,527) |
| *        Common stock and paid-in capital* | 93,718 | 86,939 |
| *        Retained earnings* | 118,848 | 84,281 |
| *        Investments - Ending balance* | (3,582) | (2,138) |
|       Cash dividends declared per common share | 2.72 | 2.48 |